The CCL11-E6E7-treated mice displayed the lowest mean tumor growth rate and a significantly prolonged survival period, with complete remission in 4 out of 5 mice whose therapeutic efficacy could be repeated (Fig. 1D, E, Fig. S1C). This evidence concerns the gene CCL11 and neoplasm.